Xconomy National

Archives

by in

Entry	Author	Date	Location
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO	Luke Timmerman	11/03/11	Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News	Erin Kutz	06/24/11	Boston
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance	Arlene Weintraub	06/20/11	Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund	Ryan McBride	01/06/11	Boston
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex	Ryan McBride	08/04/10	Boston
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News	Erin Kutz	07/16/10	Boston
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug	Ryan McBride	07/14/10	Boston
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms	Luke Timmerman	06/07/10	Boston
The Vertex Alumni: Where Are They Now?	Luke Timmerman	04/29/10	Boston
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC	Ryan McBride	04/22/10	Boston
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm	Ryan McBride	04/21/10	Boston
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer	Luke Timmerman	04/20/10	San Diego
Sirtris Founders Build New Venture Capital Fund, Keep Mum	Luke Timmerman	02/12/10	Boston
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News	Rebecca Zacks	11/13/09	Boston
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill	Luke Timmerman	11/09/09	Boston
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List	Ryan McBride	07/21/09	Boston
E Ink Scooped up by Taiwanese Display Maker, EMC Battles NetApp For Data Domain, Polatis Picks Up $8M, & More Boston-Area Deals News	Rebecca Zacks	06/05/09	Boston
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News	Rebecca Zacks	06/03/09	Boston
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential	Ryan McBride	06/02/09	Boston
Hey Life Sciences Fans, Remember The Deals Back in 2008…	Ryan McBride	01/05/09	Boston
Biotech Veteran Talks of Hedge Fund Investing, Boston Celtics, and Hot Companies	Ryan McBride	12/18/08	Boston
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News	Rebecca Zacks	10/16/08	Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV	Luke Timmerman	10/14/08	Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News	Rebecca Zacks	10/01/08	Boston
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes	Luke Timmerman	09/25/08	Boston
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News	Rebecca Zacks	05/07/08	Boston
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News	Rebecca Zacks	05/05/08	Boston
Concert Pharmaceuticals Garners $37,000,000 Series C Funding	VentureDeal	04/30/08	Boston
Page 1 of 1